C: Control; D: Rats with Alloxane-induced diabetes; D+C1: Rats treated with 125 mg/kg/day; D+C2: Rats treated with 250 mg/kg/day; D+C3: Rats treated with 375 mg/kg/day
|
| Figure 2: Effect of Karkni extract treatment on ALAT and ASAT activity
in diabetic rats. Values with different superscript letters (a,b,c) indicate
significant differences among groups at P< 0.05 by Duncan’s multiple
range test. C: Control; D: Rats with Alloxane-induced diabetes; D+C1: Rats treated with 125 mg/kg/day; D+C2: Rats treated with 250 mg/kg/day; D+C3: Rats treated with 375 mg/kg/day |
